CoChat

Design of the Effect of Adaptive Servo-Ventilation on Survival and Cardiovascular Hospital Admissions in Patients with Heart Failure and Sleep Apnoea: The ADVENT-HF Trial

Open access
Lyons, Owen D., Floras, John S., Logan, Alexander G., Beanlands, Robert, Cantolla, Joaquin Durán, Fitzpatrick, Michael, Fleetham, John, John Kimoff, R., Leung, Richard S.T., Lorenzi Filho, Geraldo, Mayer, Pierre, Mielniczuk, Lisa, Morrison, Debra L., Ryan, Clodagh M., Series, Frederic, Tomlinson, George A., Woo, Anna, Arzt, Michael, Parthasarathy, Sairam, Redolfi, Stefania, Kasai, Takatoshi, Parati, Gianfranco, Delgado, Diego H., Bradley, T. Douglas, for the ADVENT-HF Investigators · 2017 · European Journal of Heart Failure
Cited by 121

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Introduction: Both types of sleep-disordered breathing (SDB), obstructive and central sleep apnoea (OSA and CSA, respectively), are common in patients with heart failure and reduced ejection fraction (HFrEF). In such patients, SDB is associated with increased cardiovascular morbidity and mortality but it remains uncertain whether treating SDB by adaptive servo-ventilation (ASV) in such patients reduces morbidity and mortality. Aim: ADVENT-HF is designed to assess the effects of treating SDB with ASV on morbidity and mortality in patients with HFrEF. Methods: ADVENT-HF is a multicentre, multinational, randomized, parallel-group, open-label trial with blinded assessment of endpoints of standard medical therapy for HFrEF alone vs. with the addition of ASV in patients with HFrEF and SDB. Patients with a history of HFrEF undergo echocardiography and polysomnography. Those with a left ventricular ejection fraction ≤45% and SDB (apnoea–hypopnoea index ≥15) are eligible. SDB is stratified into OSA with ≥50% of events obstructive or CSA with >50% of events central. Those with OSA must not have excessive daytime sleepiness (Epworth score of ≤10). Patients are then randomized to receive or not receive ASV. The primary outcome is the composite of all-cause mortality, cardiovascular hospital admissions, new-onset atrial fibrillation requiring anti-coagulation but not hospitalization, and delivery of an appropriate discharge from an implantable cardioverter-defibrillator not resulting in hospitalization during a maximum follow-up time of 5 years. Conclusion: The ADVENT-HF trial will help to determine whether treating SDB by ASV in patients with HFrEF improves morbidity and mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.790

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

Metadata

Authors
Lyons, O. D., Floras, J. S., Logan, A. G., Beanlands, R., Cantolla, J. D., Fitzpatrick, M., Fleetham, J., John Kimoff, R., Leung, R. S. T., Lorenzi Filho, G., Mayer, P., Mielniczuk, L., Morrison, D. L., Ryan, C. M., Series, F., Tomlinson, G. A., Woo, A., Arzt, M., Parthasarathy, S., Redolfi, S., Kasai, T., Parati, G., Delgado, D. H., Bradley, T. D., & for the ADVENT-HF Investigators
Venue
European Journal of Heart Failure
Published
2017-04-01
Volume
19
Issue
4
Pages
579-587
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2604340973
Cited by
121
References
16
FWCI
11.33
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.